IL10 and neoplasm: These molecules were demonstrated to modulate the production of pro-inflammatory cytokines, decreasing TNF-α and IL-1β release and increasing anti-inflammatory cytokine interleukin-10 (IL-10) by mouse peritoneal cells, lyse human tumor-derived cells, and mouse erythrocytes [58].